Rates of Discontinuation and Nonpublication in Glioma Clinical Trials (P3-6.002)

This study aims to analyze the rates of discontinuation and nonpublication in clinical trials related to gliomas, highlighting factors that contribute to these issues.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211531
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rates of Discontinuation and Nonpublication in Glioma Clinical Trials (P3-6.002)

Mohamed Abed, Amr K. Hassan, Yusra Arafeh, Rnad Alajarmeh et al.
Neurology
Glioma Diagnosis and Treatment
article

Rates of Discontinuation and Nonpublication in Glioma Clinical Trials (P3-6.002)

Mohamed Abed, Amr K. Hassan, Yusra Arafeh, Rnad Alajarmeh, Asmaa Zakria, Nada G. Hamam, Bashar Zahir Alsalhen
article en

Abstract

This study aims to analyze the rates of discontinuation and nonpublication in clinical trials related to gliomas, highlighting factors that contribute to these issues.

NeurologyVol. 104(7_Supplement_1)
Al-Azhar University – Gaza (PS), Cairo University (EG), Jordan University of Science and Technology (JO), University of California, Irvine (US), University of Tripoli (LY), Jordan Hospital (JO), Al-Balqa Applied University (JO)
Openalex Percentile: Top 90%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.